Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 5/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.55 |
| ▸ | CASP1 | P29466 | 1/20 | 0.55 |
| ▸ | CASP7 | P55210 | 1/20 | 0.55 |
| ▸ | HBB | P68871 | 1/20 | 0.55 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.55 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.43 |
| ▸ | IDO1 | P14902 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 2/20 | 0.42 |
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
| ▸ | KDM1A | O60341 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 5/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Naphthylamine SCHEMBL28317883 | 1.00 | CYP3A4 (0.63) | CYP3A4ALDH1A1HSD17B10TDP1ALOX15 | |
| Naphthylamine SCHEMBL27635352 | 0.82 | ALDH1A1 (0.71) | CYP3A4ALDH1A1HSD17B10TDP1ALOX15 | |
| Anthracene SCHEMBL1558998 | 0.82 | CES1 (0.50) | ALDH1A1HSD17B10PTPN1IDO1CES1 | |
| Naphthylamine SCHEMBL27282006 | 0.82 | ALDH1A1 (0.94) | CYP3A4ALDH1A1HSD17B10TDP1ALOX15 | |
| Naphthalene SCHEMBL29443947 | 0.82 | CES1 (0.54) | ALDH1A1PTPN1CES1CES2KDM1A | |
| Naphthalene SCHEMBL28279265 | 0.80 | CES1 (0.48) | ALDH1A1HSD17B10HIF1APTPN1IDO1 | |
| Naphthalene SCHEMBL3935606 | 0.79 | ALDH1A1 (1.00) | CYP3A4ALDH1A1HSD17B10TDP1ALOX15 | |
| Naphthylamine SCHEMBL76713 | 0.79 | ALDH1A1 (1.00) | CYP3A4ALDH1A1HSD17B10TDP1ALOX15 | |
| Naphthylamine SCHEMBL29394720 | 0.79 | ALDH1A1 (1.00) | CYP3A4ALDH1A1HSD17B10TDP1ALOX15 | |
| Naphthylamine SCHEMBL11705209 | 0.79 | CYP3A4 (0.65) | CYP3A4ALDH1A1HSD17B10TDP1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230365563-A1 | QUINAZOLINE COMPOUND AND APPLICATION THEREOF | SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. (CN) | 2023-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230365563-A1 | QUINAZOLINE COMPOUND AND APPLICATION THEREOF | KRAS, NRAS, BRAF | CYP3A4 710/4885ALDH1A1 3174/4885HSD17B10 4369/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.